https://www.actc-ds.org/cpt_news/first-participant-enrolled-in-trc-ds/2026-05-21T18:12:02+00:00https://www.actc-ds.org/cpt_news/for-people-with-down-syndrome-a-longer-life-but-under-a-cloud/2026-04-24T20:50:56+00:00https://www.actc-ds.org/cpt_news/alzheimers-meds-are-here-but-for-the-down-syndrome-community-its-still-the-1980s/2026-04-24T20:50:36+00:00https://www.actc-ds.org/cpt_news/down-syndrome-families-fight-for-access-to-alzheimers-trials-treatments/2026-04-24T20:50:21+00:00https://www.actc-ds.org/cpt_news/down-syndrome-in-a-new-era-for-alzheimer-disease/2026-04-24T20:38:55+00:00https://www.actc-ds.org/cpt_news/why-industry-must-design-alzheimers-trials-to-include-people-with-down-syndrome/2026-04-29T20:23:20+00:00https://www.actc-ds.org/cpt_news/sindrome-de-down-y-alzheimer-como-se-relacionan/2026-04-29T20:24:09+00:00https://www.actc-ds.org/cpt_news/guia-cuidando-de-ti-y-de-mi/2026-04-29T20:24:37+00:00https://www.actc-ds.org/cpt_news/downs-syndrome-and-alzheimers-disease-in-the-economist-january-18-2025/2026-04-29T20:25:10+00:00https://www.actc-ds.org/cpt_news/reflecting-on-progress-envisioning-the-future-for-research-in-down-syndrome/2026-04-24T20:45:30+00:00https://www.actc-ds.org/cpt_news/from-clinic-to-consortium-a-new-era-of-alzheimers-trials-for-individuals-with-down-syndrome/2026-04-29T20:22:26+00:00https://www.actc-ds.org/cpt_news/downs-syndrome-and-alzheimers-disease-in-the-economist-moving-the-needle/2026-04-29T20:21:58+00:00https://www.actc-ds.org/cpt_news/down-syndrome-and-alzheimers-disease-insights-into-biomarkers-clinical-symptoms-and-pathology/2026-06-02T17:06:20+00:00https://www.actc-ds.org/cpt_news/amyloid-lowering-immunotherapies-for-alzheimer-disease-current-status-and-future-directions/2026-06-02T17:06:56+00:00https://www.actc-ds.org/cpt_news/concordance-of-biological-and-clinical-staging-of-alzheimer-disease-pathology-in-down-syndrome/2026-06-02T17:03:10+00:00https://www.actc-ds.org/cpt_news/being-brave-being-seen-and-having-your-voice-heard-perspectives-of-self-advocates-and-families-toward-accessible-and-impactful-research-of-alzheimers-disease-in-down-syndrome/2026-06-02T17:04:13+00:00https://www.actc-ds.org/cpt_news/public-and-participant-involvement-as-a-pathway-to-inclusive-dementia-research/2026-06-02T17:07:41+00:00https://www.actc-ds.org/cpt_news/a-comparative-effectiveness-study-of-lorazepam-or-ivig-versus-no-treatment-for-down-syndrome-regression-disorder/2026-06-02T16:58:51+00:00https://www.actc-ds.org/cpt_news/relationship-of-cholinergic-basal-forebrain-atrophy-with-the-time-course-of-alzheimers-disease-pathology-and-cognitive-decline-in-adults-with-down-syndrome-a-longitudinal-cohort-study/2026-06-02T17:02:41+00:00https://www.actc-ds.org/cpt_news/decoding-alzheimers-disease-through-down-syndrome-insights-from-a-genetically-defined-population/2026-06-02T16:57:35+00:00https://www.actc-ds.org/cpt_news/precision-medicine-for-alzheimers-disease-in-down-syndrome/2026-06-02T16:55:21+00:00https://www.actc-ds.org/cpt_news/michael-rafii-named-1-down-syndrome-researcher-worldwide-for-sixth-consecutive-year/2026-05-01T22:30:47+00:00https://www.actc-ds.org/cpt_news/volunteers-with-downs-syndrome-could-help-find-alzheimers-drugs/2026-05-01T22:33:25+00:00https://www.actc-ds.org/cpt_news/how-to-improve-clinical-trials/2026-05-01T22:35:08+00:00https://www.actc-ds.org/cpt_news/include-project/2026-05-01T22:37:10+00:00https://www.actc-ds.org/cpt_news/phase-2-applauds-trial-to-test-mivelsiran-in-down-syndrome-associated-alzheimer-disease/2026-07-17T18:18:49+00:00